Marjan Cruijsen

2PUBLICATIONS
3CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 07, 2021
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation.

Marjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden

Pageof 1